Company Filing History:
Years Active: 2022
Title: The Innovations of Peter James
Introduction
Peter James is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His work focuses on innovative methods for treating pain, showcasing his commitment to advancing medical science.
Latest Patents
Peter James holds a patent for "Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins." This invention includes a single chain polypeptide fusion protein that consists of a non-cytotoxic protease capable of cleaving a protein of the exocytic fusion apparatus of a nociceptive sensory afferent, a galanin targeting moiety, a protease cleavage site, a translocation domain, and two spacers located strategically within the structure.
Career Highlights
Throughout his career, Peter has worked with prominent companies in the biotechnology sector, including Ipsen Bioinnovation Limited and Allergan, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.
Collaborations
Peter has collaborated with esteemed colleagues such as Keith Foster and John Andrew Chaddock. These partnerships have fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
Peter James is a distinguished inventor whose work in fusion proteins has the potential to revolutionize pain management. His dedication to innovation and collaboration continues to inspire advancements in biotechnology.